We are monitoring the impact of COVID-19 on Asia Pacific Cell Counting Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 5768
Share on
Share on

Asia Pacific Cell Counting Market Research Report – Segmented By Product, Consumables, End User & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Size, Share, Trends, Growth, Forecast | 2021 to 2026

Pulished: April, 2021
ID: 5768
Pages: 145

APAC Cell Counting Market Size & Growth (2021 to 2026):

According to the report, the Asia-Pacific Cell Counting Market Size is valued at USD 0.19 billion in 2021 and projected to grow at a CAGR of 7.2%, to reach USD 0.27 billion by 2026 during the forecast period 2021 to 2026.

DRIVERS

The APAC cell counting market is expected to grow significantly during the forecast period. The growing demand for advanced healthcare facilities in emerging economies like China and the collaboration among market players for the development of innovative products are other factors which are significantly contributing to the growth of the market. Increased government funding for scientific research has fostered the rapid development of stem cell research in China. For example, the Chinese government and the UK government adopted a program related to stem cell research called the UK-China Stem Cell Partnership Initiative.

Factors that increase the cell counting market have focus on cell counting in the diagnosis and treatment of terminal diseases such as cancer, as well as a wide range of cell counting applications. For example, according to the American Cancer Society, nearly 1,689,000 new cases of cancer are expected in 2018, and about 600,000 deaths from it. In addition, the increase in healthcare expenses and the use of new cell counting technologies have led to the growth of the market.

RESTRAINTS

However, the high prices of advanced cell counting systems and the lack of awareness of researchers to use advanced cell counting techniques are limiting the growth of this market to some extent.

OPPORTUNITIES

The cell counting market is expected to show a good growth due to the growing focus on regenerative medicine & a significant number of biotechnology and biopharmaceutical companies in the APAC regions.

CHALLENGES

High cost of instruments and lack of goof healthcare infrastructure in developing countries are challenging the market growth rate.

This research report on the Asia Pacific Cell Counting Market has been segmented and sub-segmented into the following categories.

By Product:

  • Instruments
  • Cell Counters
  • Hematology Analysers
  • Spectrophotometer
  • Flow Cytometer
  • Hemocytometer
  • Others

By Consumables:

  • Microplates
  • Reagent
  • Assay Kits

By End User:

  • Pharmaceutical & Biotechnology Industries
  • Hospitals & Diagnostic Laboratories
  • Research & Academic Institutes

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

REGIONAL ANALYSIS

The increasing number of diagnostic procedures for various chronic diseases and the increasing availability of cost-effective diagnostic tests are driving the growth of the market. In addition, less complex regulations for drug development in the Asian region have boosted the growth of the market.

Japan accounts for the largest market share in the APAC cell counting market in 2019. The market growth is attributed to the development of medical devices, in addition to research and development activities. In addition, the major companies are involved in the export of medical devices by targeting developing markets to capture reasonable market share. In addition, according to the National Institute of Health, China has been able to establish around 110 stem cell banks; there are currently 11 stem cell drugs under approval, and in 2018, more than 410 stem cell clinical trials were registered in the country. Therefore, these initiatives towards stem cell therapy offer a vast opportunity for the cell counting industry.

India is considered the fastest growing market for medical device manufacturers. In India, the cell counting market is growing due to the availability of low cost raw materials, better access to labor and an increasing number of hospitals and healthcare facilities. India is one of the major destinations for medical tourism especially for orthopedic surgeries which further influences the growth of the market. There is a steady growth of this market in Australia and Republic of Korea during the forecast period 2020-2026.

Key Market Companies Operating the Asia Pacific Cell Counting Market are Thermo Fisher Scientific, Inc., Danaher Corporation, Agilent Technologies, Bio-Rad Laboratories, Merck Millipore, Inc., GE Healthcare, Becton, Dickinson and Company, and PerkinElmer, Inc.

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemiology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Product                                        

                                5.1.1 Introduction                           

                                5.1.2 Instruments                           

                                                5.1.2.1 Cell Counters      

                                                                5.1.2.1.1 Automated Cell Counters

                                                                5.1.2.1.2 Hemocytometers and Manual Cell Counters

                                                5.1.2.2 Hematology Analysers   

                                                5.1.2.3 Spectrophotometer        

                                                                5.1.2.3.1 Single-Mode Readers

                                                                5.1.2.3.2 Multi-Mode Readers

                                                5.1.2.4 Flow Cytometer

                                                5.1.2.5 Hemocytometer               

                                                5.1.2.6 Others   

                                5.1.3 Consumables                         

                                                5.1.3.1 Microplates         

                                                5.1.3.2 Reagents              

                                                5.1.3.3 Assay Kits             

                                                5.1.3.4 Accessories         

                                                5.1.3.5 Others   

                                5.1.4 Y-o-Y Growth Analysis, By Product                               

                                5.1.5 Market Attractiveness Analysis, By Product                             

                                5.1.6 Market Share Analysis, By Product                               

                5.2 End-user                                      

                                5.2.1 Introduction                           

                                5.2.2 Pharmaceutical & Biotechnology Industries                              

                                5.2.3 Hospitals & Diagnostic Laboratories                              

                                5.2.4 Research & Academic Institutes                    

                                5.2.5 Others                      

                                5.2.6 Y-o-Y Growth Analysis, By End-user                             

                                5.2.7 Market Attractiveness Analysis, By End-user                           

                                5.2.8 Market Share Analysis, By End-user                             

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Product           

                                                6.1.3.3 By End-user        

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Product           

                                                6.1.4.3 By End-user        

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Product           

                                                6.1.5.3 By End-user        

                6.2 China                                             

                6.3 India                                              

                6.4 Japan                                            

                6.5 South Korea                                               

                6.6 Australia      

                6.7 Rest of Asia Pacific                                

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8. Market Leaders' Analysis                                                        

                8.1 Thermo Fisher Scientific, Inc.,                                             

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Danaher Corporation                                             

                8.3 Agilent Technologies                                              

                8.4 Bio-Rad Laboratories                                              

                8.5 Merck Millipore, Inc.,                                             

                8.6 GE Healthcare                                           

                8.7 Becton, Dickinson and Company                                       

                8.8 PerkinElmer, Inc.                                      

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, Collaborations, and Joint Ventures                                         

                9.4 New Product Launches                                         

10. Market Outlook and Investment Opportunities                                                         

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of Pharmaceutical & Biotechnology Industries, Hospitals with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Cell Counting  Market By Product, From 2021 to 2026 ( USD Billion )
  2. Asia Pacific Instruments Market By Region, From 2021 to 2026 ( USD Billion )
  3. Asia Pacific Consumables Market By Region, From 2021 to 2026 ( USD Billion )
  4. Asia Pacific Cell Counting  Market By End User , From 2021 to 2026 ( USD Billion )
  5. Asia Pacific Pharmaceutical & Biotechnology Industries Market By Region, From 2021 to 2026 ( USD Billion )
  6. Asia Pacific Hospitals & Diagnostic Laboratories Market By Region, From 2021 to 2026 ( USD Billion )
  7. Asia Pacific Research & Academic Institutes Market By Region, From 2021 to 2026 ( USD Billion )
  8. Asia Pacific Others Market By Region, From 2021 to 2026 ( USD Billion )
  9. Japan Cell Counting  Market By Product, From 2021 to 2026 ( USD Billion )
  10. Japan Cell Counting  Market By End User , From 2021 to 2026 ( USD Billion )
  11. China Cell Counting  Market By Product, From 2021 to 2026 ( USD Billion )
  12. China Cell Counting  Market By End User , From 2021 to 2026 ( USD Billion )
  13. India Cell Counting  Market By Product, From 2021 to 2026 ( USD Billion )
  14. India Cell Counting  Market By End User , From 2021 to 2026 ( USD Billion )
  15. Australia Cell Counting  Market By Product, From 2021 to 2026 ( USD Billion )
  16. Australia Cell Counting  Market By End User , From 2021 to 2026 ( USD Billion )
  17. South Korea Cell Counting  Market By Product, From 2021 to 2026 ( USD Billion )
  18. South Korea Cell Counting  Market By End User , From 2021 to 2026 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample